Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients...
Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy [version 2; peer review: 2 approved, 1 approved with reservations]
About this item
Full title
Author / Creator
Publisher
London, UK: F1000 Research Limited
Journal title
Language
English
Formats
Publication information
Publisher
London, UK: F1000 Research Limited
More information
Scope and Contents
Contents
Background: The 7+3 regimen is still the main choice of remission induction chemotherapy in acute myeloid leukemia (AML). Successfully achieving complete remission (CR) and the time required to achieve it determine patient's survival. Hence, bone marrow examination on 14
th day of chemotherapy is recommended to predict CR. However, the examinati...
Alternative Titles
Full title
Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy [version 2; peer review: 2 approved, 1 approved with reservations]
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9194516
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9194516
Other Identifiers
ISSN
2046-1402
E-ISSN
2046-1402
DOI
10.12688/f1000research.110320.2
